p53 protein expression in nephroblastomas: a predictor of poor prognosis
1998

p53 Protein Expression in Nephroblastomas and Its Prognostic Value

Sample size: 93 publication Evidence: high

Author Information

Author(s): D Govender, P HariIal, GP Hadley, R Chetty

Primary Institution: University of Natal Medical School and King Edward VII Hospital

Hypothesis

Is p53 immunoexpression a predictor of poor prognosis in nephroblastomas?

Conclusion

High p53 immunoexpression in nephroblastomas is associated with a shorter survival period and identifies patients with unfavourable histology tumours.

Supporting Evidence

  • 71.4% of unfavourable histology tumours showed high p53 expression.
  • Mean survival for low p53 expression was 24.8 months, while for high it was 12.6 months.
  • Statistical significance was found between p53 expression and histological classification.

Takeaway

This study found that if a child's kidney tumor has a lot of a certain protein called p53, it might mean they won't live as long. It helps doctors know which tumors are more dangerous.

Methodology

The study analyzed 93 nephroblastoma cases using immunohistochemical staining for p53 protein and correlated findings with histological classification, disease stage, and survival.

Limitations

The study may not have valid results for stage V tumors due to a small number of patients.

Participant Demographics

49 female and 44 male patients, ages ranged from 4 months to 14 years, mean age 3 years 7 months.

Statistical Information

P-Value

p=0.0003

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication